Autoantibodies against Muscarinic Receptors in Breast Cancer: Their Role in Tumor Angiogenesis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Lombardi, María Gabriela ^a   Negroni, María Pía ^b   Pelegrina, Laura Tatiana ^a   Castro, María Ester ^a   Fiszman, Gabriel L ^c   Azar, María Eugenia ^c   Morgado, Carlos Cresta ^c   Sales, María Elena ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; MUSCARINIC RECEPTOR; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER STAGING; CELL STRAIN MCF 7; CONTROLLED STUDY; CROSS REACTION; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; ANTIBODIES, NEOPLASM; AUTOANTIBODIES; BREAST NEOPLASMS; CARBACHOL; FEMALE; FIBROADENOMA; HUMANS; IMMUNOGLOBULIN G; MCF-7 CELLS; MICE; MICE, NUDE; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, MUSCARINIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874517911     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057572     Document Type: Article

References (24)

1. Fernández Madrid F, Tang N, Alansari H, Karvonen RL, Tomkiel JE, (2005) Improved approach to identify cancer-associated autoantigens. Autoimmun Rev 4: 230-235.
2. Chapman C, Murray A, Chakrabarti J, Thorpe A, Woolston C, et al. (2007) Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol 18: 868-873.
3. Shah N, Khurana S, Cheng K, Raufman JP, (2009) Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol 296: C221-C232.
4. Eglen RM, (2005) Muscarinic receptor subtype pharmacology and physiology. Prog Med Chem 43: 105-136.
5. Fiszman GL, Sales ME, (2008) Antibodies against muscarinic receptors in breast cancer: Agonizing tumor growth. Curr Immunol Rev 4: 1-7.
6. Negroni MP, Fiszman GL, Azar ME, Morgado CC, Español AJ, et al. (2010) Immunoglobulin G from breast cancer patients in stage I stimulates muscarinic acetylcholine receptors in MCF7 cells and induces proliferation. Participation of nitric oxide synthase-derived nitric oxide. J Clin Immunol. 3: 478-484.
7. Folkman J, (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6: 273-286.
8. Ferrara N, Gerber HP, LeCouter J, (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676.
9. Urtreger AJ, Ladeda VE, Puricelli L, Rivelli A, Vidal MC, et al. (1997) Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two murine mammary tumor cell lines. Int J Oncol 11: 489-496.
10. Chen TR, (1977) In situ detection of micoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res 104: 255-262.
11. Bradford MM, (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
12. Davel LE, Rimmaudo L, Español A, de la Torre E, Jasnis MA, et al. (2004) Different mechanisms lead to the angiogenic process induced by three adenocarcinoma cell lines. Angiogenesis 7: 45-51.
13. Monte M, Davel L, Sacerdote de Lustig E, (1997) Hydrogen peroxide is involved in lymphocyte activation mechanisms to induce angiogenesis. Eur J Cancer 133: 676-682.
14. Kasukabe T, Okabe-Kado J, Kato N, Sassa T, Honma Y, (2005) Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts. Breast Cancer Res 7: R1097-R1110.
15. Dvorak HF, (2002) Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20: 4368-4380.
16. Hicklin DJ, Ellis LM, (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23: 1011-1027.
17. Español AJ, Sales ME, (2004) Different muscarinic receptors are involved in the proliferation of murine mammary adenocarcinoma cell lines. Int J Mol Med 13: 311-319.
18. Rimmaudo LE, de la Torre E, Sacerdote de Lustig E, Sales ME, (2005) Muscarinic receptors are involved in LMM3 tumor cell proliferation and angiogenesis. Biochem Biophys Res Commun 334: 1359-1364.
19. Fiszman G, Middonno MC, de la Torre E, Farina M, Español A, et al. (2007) Activation of muscarinic cholinergic receptors induces MCF-7 cells proliferation and angiogenesis by stimulating nitric oxide synthase activity. Cancer Biol Ther 6: 1106-1113.
20. Fernández Madrid F, (2005) Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis. Cancer Lett 230: 187-198.
21. Fiszman G, Cattaneo V, de la Torre E, Español A, Colombo L, et al. (2006) Muscarinic receptors autoantibodies purified from mammary adenocarcinoma-bearing mice sera stimulate tumor progression. Int Immunopharmac 6: 1323-1330.
22. Pelegrina LT, Lombardi MG, Fiszman GL, Azar ME, Morgado CC, et al. (2012) Immunoglobulin G from Breast Cancer Patients Regulates MCF-7 Cells Migration and MMP-9 Activity by Stimulating Muscarinic Acetylcholine Receptors. J Clin Immunol. In press.
23. John A, Tuszynski G, (2001) The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7: 14-23.
24. Hawinkels LJ, Zuidwijk K, Verspaget HW, de Jonge-Muller ES, van Duijn W, et al. (2008) VEGF release by MMP-9 mediated heparin sulphate cleavage induces colorectal cancer angiogenesis. Eur J Cancer 44: 1904-1913.